{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:56:58Z","timestamp":1790006218070,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T00:00:00Z","timestamp":1173139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T00:00:00Z","timestamp":1173139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1007\/s10875-007-9072-4","type":"journal-article","created":{"date-parts":[[2007,3,5]],"date-time":"2007-03-05T18:43:19Z","timestamp":1173120199000},"page":"327-338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Structural and Functional Properties of Antibodies to the Superantigen TSST-1 and Their Relationship to Menstrual Toxic Shock Syndrome"],"prefix":"10.1007","volume":"27","author":[{"given":"Rita","family":"Kansal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Hansmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Seymour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Parsonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Modern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malak","family":"Kotb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,3,6]]},"reference":[{"issue":"Suppl 11","key":"9072_CR1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/clinids\/11.Supplement_1.S107","volume":"11","author":"PM Schlievert","year":"1989","unstructured":"Schlievert PM: Role of toxic shock syndrome toxin 1 in toxic shock syndrome: Overview. Rev Infect Dis 11(Suppl 11):107\u2013109, 1989","journal-title":"Rev Infect Dis"},{"key":"9072_CR2","unstructured":"Schlievert PM, Bohach GA, Hovde CJ, Kreiswirth BN, Novick RP: Molecular studies of toxic shock syndrome-associated staphylococcal and streptococcal toxins. In Molecular Biology of Staphylococci, RP Novick (ed). New York, VCH, 1990, pp 313\u2013326"},{"key":"9072_CR3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/infdis\/143.4.509","volume":"143","author":"PM Schlievert","year":"1981","unstructured":"Schlievert PM, Shands KN, Dan BB, Schmid GP, Nishimura RD: Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic shock syndrome. J Infect Dis 143:509\u2013516, 1981","journal-title":"J Infect Dis"},{"key":"9072_CR4","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/S0140-6736(78)92274-2","volume":"2","author":"J Todd","year":"1978","unstructured":"Todd J, Fishaut M, Kapral F, Welch T: Toxic-shock syndrome associated with phage-group-I staphylococci. Lancet 2:1116\u20131118, 1978","journal-title":"Lancet"},{"key":"9072_CR5","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/NEJM198012183032501","volume":"303","author":"JP Davis","year":"1980","unstructured":"Davis JP, Chesney PJ, Wand PJ, LaVenture M: Toxic-shock syndrome: Epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med 303:1429\u20131435, 1980","journal-title":"N Engl J Med"},{"key":"9072_CR6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/infdis\/145.4.431","volume":"145","author":"MT Osterholm","year":"1982","unstructured":"Osterholm MT, Davis JP, Gibson RW, Mandel JS, Wintermeyer LA, Helms CM, Forfang JC, Rondeau J, Vergeront JM: Tri-state toxic-state syndrome study. I. Epidemiologic findings. J Infect Dis 145:431\u2013440, 1982","journal-title":"J Infect Dis"},{"key":"9072_CR7","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1001\/jama.248.7.835","volume":"248","author":"WF Schlech","year":"1982","unstructured":"Schlech WF III, Shands KN, Reingold AL, Dan BB, Schmid GP, Hargrett NT, Hightower A, Herwaldt LA, Neill MA, Band JD, et\u00a0al.: Risk factors for development of toxic shock syndrome. Association with a tampon brand. JAMA 248:835\u2013839, 1982","journal-title":"JAMA"},{"key":"9072_CR8","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJM198012183032502","volume":"303","author":"KN Shands","year":"1980","unstructured":"Shands KN, Schmid GP, Dan BB, Blum D, Guidotti RJ, Hargrett NT, Anderson RL, Hill DL, Broome CV, Band JD, et\u00a0al.: Toxic-shock syndrome in menstruating women: Association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med 303:1436\u20131442, 1980","journal-title":"N Engl J Med"},{"key":"9072_CR9","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/00001432-199206000-00010","volume":"5","author":"M Kotb","year":"1992","unstructured":"Kotb M: Role of superantigens in the pathogenesis of infectious diseases and their sequelae. Curr Opin Infect Dis 5:364\u2013374, 1992","journal-title":"Curr Opin Infect Dis"},{"key":"9072_CR10","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/nm800","volume":"8","author":"M Kotb","year":"2002","unstructured":"Kotb M, Norrby-Teglund A, McGeer A, El-Sherbini H, Dorak MT, Khurshid A, Green K, Peeples J, Wade J, Thomson G, et\u00a0al.: An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med 8:1398\u20131404, 2002","journal-title":"Nat Med"},{"key":"9072_CR11","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1002\/1521-4141(200011)30:11<3247::AID-IMMU3247>3.0.CO;2-D","volume":"30","author":"A Norrby-Teglund","year":"2000","unstructured":"Norrby-Teglund A, Chatellier S, Low DE, McGeer A, Green K, Kotb M: Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur J Immunol 30:3247\u20133255, 2000","journal-title":"Eur J Immunol"},{"key":"9072_CR12","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1128\/IAI.67.4.1871-1877.1999","volume":"67","author":"H Basma","year":"1999","unstructured":"Basma H, Norrby-Teglund A, Guedez Y, McGeer A, Low DE, El-Ahmedy O, Schwartz B, Kotb M: Risk factors in the pathogenesis of invasive group A streptococcal infections: Role of protective humoral immunity. Infect Immun 67:1871\u20131877, 1999","journal-title":"Infect Immun"},{"key":"9072_CR13","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1086\/317423","volume":"31","author":"A Norrby-Teglund","year":"2000","unstructured":"Norrby-Teglund A, Ihendyane N, Kansal R, Basma H, Kotb M, Andersson J, Hammarstrom L: Relative neutralizing activity in polyspecific IgM, IgA, and IgG preparations against group A streptococcal superantigens. Clin Infect Dis 31:1175\u20131182, 2000","journal-title":"Clin Infect Dis"},{"key":"9072_CR14","doi-asserted-by":"crossref","first-page":"S482","DOI":"10.1093\/clinids\/9.Supplement_5.S482","volume":"9","author":"EH Kass","year":"1987","unstructured":"Kass EH, Parsonnet J: On the pathogenesis of toxic shock syndrome. Rev Infect Dis 9:S482\u2013S489, 1987","journal-title":"Rev Infect Dis"},{"key":"9072_CR15","doi-asserted-by":"publisher","first-page":"4628","DOI":"10.1128\/JCM.43.9.4628-4634.2005","volume":"43","author":"J Parsonnet","year":"2005","unstructured":"Parsonnet J, Hansmann MA, Delaney ML, Modern PA, Dubois AM, Wieland-Alter W, Wissemann KW, Wild JE, Jones MB, Seymour JL, et\u00a0al.: Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women. J Clin Microbiol 43:4628\u20134634, 2005","journal-title":"J Clin Microbiol"},{"key":"9072_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S1068-607X(00)00027-5","volume":"7","author":"MA Reiss","year":"2000","unstructured":"Reiss MA: Toxic shock syndrome. Prim Care Update Ob Gyns 7:85\u201390, 2000","journal-title":"Prim Care Update Ob Gyns"},{"key":"9072_CR17","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/infdis\/150.5.662","volume":"150","author":"PF Bonventre","year":"1984","unstructured":"Bonventre PF, Linnemann C, Weckbach LS, Staneck JL, Buncher CR, Vigdorth E, Ritz H, Archer D, Smith B: Antibody responses to toxic-shock-syndrome (TSS) toxin by patients with TSS and by healthy staphylococcal carriers. J Infect Dis 150:662\u2013666, 1984","journal-title":"J Infect Dis"},{"key":"9072_CR18","first-page":"87","volume":"93","author":"B Christensson","year":"1985","unstructured":"Christensson B, Hedstrom SA: Serological response to toxic shock syndrome toxin in Staphylococcus aureus infected patients and healthy controls. Acta Pathol Microbiol Immunol Scand B 93:87\u201390, 1985","journal-title":"Acta Pathol Microbiol Immunol Scand B"},{"key":"9072_CR19","first-page":"443","volume":"66","author":"B Christensson","year":"1986","unstructured":"Christensson B, Johansson PJ, Oxelius VA: Imbalanced serum IgG subclass pattern in toxic shock syndrome patients: Deficiency of specific IgG1 and IgG4 subclass antibodies to toxic shock syndrome toxin 1. Clin Exp Immunol 66:443\u2013449, 1986","journal-title":"Clin Exp Immunol"},{"key":"9072_CR20","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1093\/clinids\/11.Supplement_1.S8","volume":"11","author":"JA Jacobson","year":"1989","unstructured":"Jacobson JA, Kasworm E, Daly JA: Risk of developing toxic shock syndrome associated with toxic shock syndrome toxin 1 following nongenital staphylococcal infection. Rev Infect Dis 11:S8\u2013S13, 1989","journal-title":"Rev Infect Dis"},{"key":"9072_CR21","first-page":"187","volume":"11","author":"PM Rosten","year":"1988","unstructured":"Rosten PM, Bartlett KH, Chow AW: Serologic responses to toxic shock syndrome (TSS) toxin-1 in menstrual and nonmenstrual TSS. Clin Invest Med 11:187\u2013192, 1988","journal-title":"Clin Invest Med"},{"key":"9072_CR22","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/infdis\/151.5.883","volume":"151","author":"SJ Stolz","year":"1985","unstructured":"Stolz SJ, Davis JP, Vergeront JM, Crass BA, Chesney PJ, Wand PJ, Bergdoll MS: Development of serum antibody to toxic shock toxin among individuals with toxic shock syndrome in Wisconsin. J Infect Dis 151:883\u2013889, 1985","journal-title":"J Infect Dis"},{"key":"9072_CR23","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1128\/iai.64.12.5395-5398.1996","volume":"62","author":"A Norrby-Teglund","year":"1996","unstructured":"Norrby-Teglund A, Kaul R, Low DE, McGeer A, Andersson JP, Andersson UG, Kotb M: Evidence for the presence of streptococcal superantigen neutralizing antibodies in normal polyspecific IgG (IVIG). Infect Immun 62:5395\u20135398, 1996","journal-title":"Infect Immun"},{"key":"9072_CR24","doi-asserted-by":"crossref","first-page":"875","DOI":"10.7326\/0003-4819-96-6-875","volume":"96","author":"AL Reingold","year":"1982","unstructured":"Reingold AL, Hargrett NT, Shands KN, Dan BB, Schmid GP, Strickland BY, Broome CV: Toxic shock syndrome surveillance in the United States, 1980 to 1981. Ann Intern Med 96:875\u2013880, 1982","journal-title":"Ann Intern Med"},{"key":"9072_CR25","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/S0140-6736(81)92186-3","volume":"1","author":"MS Bergdoll","year":"1981","unstructured":"Bergdoll MS, Crass BA, Reiser RF, Robbins RN, Davis JP: A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet 1:1017\u20131021, 1981","journal-title":"Lancet"},{"key":"9072_CR26","unstructured":"Johnson WM, Tyler SD: PCR detection of genes for enterotoxins, exfoliative toxins, and toxic shock syndrome toxin-1 in Staphylococcus aureus. In Diagnostic Molecular Microbiology: Principles and Applications. Washington, DC, American Society for Microbiology, 1993, pp 294\u2013299"},{"key":"9072_CR27","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1086\/503048","volume":"193","author":"S Holtfreter","year":"2006","unstructured":"Holtfreter S, Roschack K, Eichler P, Eske K, Holtfreter B, Kohler C, Engelmann S, Hecker M, Greinacher A, Broker BM: Staphylococcus aureus carriers neutralize superantigens by antibodies specific for their colonizing strain: A potential explanation for their improved prognosis in severe sepsis. J Infect Dis 193:1275\u20131278, 2006","journal-title":"J Infect Dis"},{"key":"9072_CR28","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1016\/S0264-410X(02)00400-0","volume":"20","author":"JM Gampfer","year":"2002","unstructured":"Gampfer JM, Samstag A, Waclavicek M, Wolf HM, Eibl MM, Gulle H: Epitope mapping of neutralizing TSST-1 specific antibodies induced by immunization with toxin or toxoids. Vaccine 20:3675\u20133684, 2002","journal-title":"Vaccine"},{"key":"9072_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.femsim.2005.01.010","volume":"45","author":"JC Cui","year":"2005","unstructured":"Cui JC, Hu DL, Lin YC, Qian AD, Nakane A: Immunization with glutathione S-transferase and mutant toxic shock syndrome toxin 1 fusion protein protects against Staphylococcus aureus infection. FEMS Immunol Med Microbiol 45:45\u201351, 2005","journal-title":"FEMS Immunol Med Microbiol"},{"key":"9072_CR30","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1001\/jama.258.7.917","volume":"258","author":"SF Berkley","year":"1987","unstructured":"Berkley SF, Hightower AW, Broome CV, Reingold AL: The relationship of tampon characteristics to menstrual toxic shock syndrome. JAMA 258:917\u2013920, 1987","journal-title":"JAMA"},{"key":"9072_CR31","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/0895-4356(90)90105-X","volume":"43","author":"SF Lanes","year":"1990","unstructured":"Lanes SF, Rothman KJ: Tampon absorbency, composition and oxygen content and risk of toxic shock syndrome. J Clin Epidemiol 43:1379\u20131385, 1990","journal-title":"J Clin Epidemiol"},{"issue":"Suppl 1","key":"9072_CR32","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/clinids\/11.Supplement_1.S35","volume":"11","author":"AL Reingold","year":"1989","unstructured":"Reingold AL, Broome CV, Gaventa S, Hightower AW: Risk factors for menstrual toxic shock syndrome: Results of a multistate case-control study. Rev Infect Dis 11(Suppl 1):S35\u2013S41 (discussion S41\u2013S32), 1989","journal-title":"Rev Infect Dis"},{"key":"9072_CR33","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1128\/IAI.73.4.2164-2174.2005","volume":"73","author":"ML Peterson","year":"2005","unstructured":"Peterson ML, Ault K, Kremer MJ, Klingelhutz AJ, Davis CC, Squier CA, Schlievert PM: The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1. Infect Immun 73:2164\u20132174, 2005","journal-title":"Infect Immun"},{"key":"9072_CR34","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/BF01956412","volume":"153","author":"S Higuchi","year":"1994","unstructured":"Higuchi S, Awata H, Nunoi H, Tsuchiya H, Naoe H, Igarashi H, Matsuda I: A family of selective immunodeficiency with normal immunoglobulins: Possible autosomal dominant inheritance. Eur J Pediatr 153:328\u2013332, 1994","journal-title":"Eur J Pediatr"},{"key":"9072_CR35","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S0140-6736(87)91372-9","volume":"2","author":"M Monteil","year":"1987","unstructured":"Monteil M, Hobbs J, Citron K: Selective immunodeficiency affecting staphylococcal response. Lancet 2:880\u2013883, 1987","journal-title":"Lancet"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-007-9072-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-007-9072-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-007-9072-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-007-9072-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T01:23:59Z","timestamp":1652837039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-007-9072-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,6]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["9072"],"URL":"https:\/\/doi.org\/10.1007\/s10875-007-9072-4","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,6]]},"assertion":[{"value":"20 July 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}